lobbying_activities: 2970860

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2970860	c593a642-9c9d-45a2-927b-fe2a4bdee017	1T	E3 STRATEGIC CONSULTING GROUP	401104104	HEINZ STRATEGIES LLC (ON BEHALF OF PILMA)	2023	first_quarter	PHA	Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023.	HOUSE OF REPRESENTATIVES,SENATE			0	1	2023-04-19T15:26:11-04:00